傻逼五毛賤畜又想造謠甩鍋了
該醫學期刊報告只是說明
武漢肺炎可能早在2020年1月19日之前就傳入美國而已
該報告還引用柳葉刀的報告表明
一名武漢肺炎確診者早在2019年12月1日就在武漢住院並出現症狀
說明武漢肺炎在更早之前可能就開始在武漢傳播了
原文節錄
Abstract
Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in December 2019, with subsequent worldwide spread. The first US cases were identified in January 2020.
Methods
To determine if SARS-CoV-2–reactive antibodies were present in sera prior to the first identified case in the United States on 19 January 2020, residual archived samples from 7389 routine blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020 from donors resident in 9 states (California, Connecticut, Iowa, Massachusetts, Michigan, Oregon, Rhode Island, Washington, and Wisconsin) were tested at the Centers for Disease Control and Prevention for anti–SARS-CoV-2 antibodies. Specimens reactive by pan-immunoglobulin (pan-Ig) enzyme-linked immunosorbent assay (ELISA) against the full spike protein were tested by IgG and IgM ELISAs, microneutralization test, Ortho total Ig S1 ELISA, and receptor-binding domain/ACE2 blocking activity assay.
Results
Of the 7389 samples, 106 were reactive by pan-Ig. Of these 106 specimens, 90 were available for further testing. Eighty-four of 90 had neutralizing activity, 1 had S1 binding activity, and 1 had receptor-binding domain/ACE2 blocking activity >50%, suggesting the presence of anti–SARS-CoV-2–reactive antibodies. Donations with reactivity occurred in all 9 states.
Conclusions
These findings suggest that SARS-CoV-2 may have been introduced into the United States prior to 19 January 2020.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the novel coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China [1评]
原文節錄
Abstract
Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in December 2019, with subsequent worldwide spread. The first US cases were identified in January 2020.
Methods
To determine if SARS-CoV-2–reactive antibodies were present in sera prior to the first identified case in the United States on 19 January 2020, residual archived samples from 7389 routine blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020 from donors resident in 9 states (California, Connecticut, Iowa, Massachusetts, Michigan, Oregon, Rhode Island, Washington, and Wisconsin) were tested at the Centers for Disease Control and Prevention for anti–SARS-CoV-2 antibodies. Specimens reactive by pan-immunoglobulin (pan-Ig) enzyme-linked immunosorbent assay (ELISA) against the full spike protein were tested by IgG and IgM ELISAs, microneutralization test, Ortho total Ig S1 ELISA, and receptor-binding domain/ACE2 blocking activity assay.
Results
Of the 7389 samples, 106 were reactive by pan-Ig. Of these 106 specimens, 90 were available for further testing. Eighty-four of 90 had neutralizing activity, 1 had S1 binding activity, and 1 had receptor-binding domain/ACE2 blocking activity >50%, suggesting the presence of anti–SARS-CoV-2–reactive antibodies. Donations with reactivity occurred in all 9 states.
Conclusions
These findings suggest that SARS-CoV-2 may have been introduced into the United States prior to 19 January 2020.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the novel coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, with notification to the World Health Organization on 31 December 2019, about a cluster of pneumonia cases of unknown etiology an [1评]
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the novel coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, with notification to the World Health Organization on 31 December 2019, about a cluster of pneumonia cases of unknown etiology and release of the genomic sequence on 10 January 2020 [1]. Subsequent reports have identified a patient with confirmed SARS-CoV-2 hospitalized in Wuhan with symptom onset as early as 1 December 2019 [2]. In the United States, the first COVID-19 infection was reported on 19 January 2020 in a returned traveler from China, 2 days after domestic testing was initiated [3]. While the first confirmed case had a symptom-onset date of 19 January 2020, 2 others within the first 12 US cases identified had illness-onset dates of 14 January 2020 [4]. Some reports have suggested the introduction of SARS-CoV-2 into the United States may have occurred earlier than initially recognized, although widespread community transmission was not likely until late February [5–7]. [1评]
“中国欠我们在新冠疫情上花费的4万亿美元。”
当地时间1月12日，美国共和党政客简·亚当斯（Jane Adams）在推特发文叫嚣，称中国应该赔偿美国花在新冠疫情上的4万亿美元。她之后又发了一条推特，专门在原文的“新冠疫情”之前补上了“抗击”一词。此事引发众多网民嘲讽，“是美国开发生化武器的费用？”还有人直接发出“4万亿冥币”，回敬亚当斯。
根据简·亚当斯的竞选网站介绍，她来自于美国内华达州拉斯维加斯，是2024年国会选举的共和党候选人。她的竞选主张包括削减政府开支、投资美国本土制造业、推广使用比特币支付、推动内华达州能源独立等等。
12日，亚当斯在推特发文，称“中国欠我们在新冠疫情上花费的4万亿美元。”她可能觉得自己的话有歧义，于是又立马补发了一条，专门加上了“抗击（battling）”一词：“中国欠我们在抗击新冠疫情上花费的4万亿美元。”
她的言论遭到众多网民嘲讽回怼：“是美国开发生化武器的费用。”“是的，疫情在中国爆发，但美国应该对此负责。”
“2023年了，还能看到这样的评论。你们印的所有的钱，代价是全世界的通货膨胀。”
“你应该为传播错误信息向选民道歉。”
有网民直接甩出了4张“一万亿元”面额的冥币，回敬亚当斯：
“你太搞笑了，哈哈，去找你的政府要钱吧，到那儿顺便问下关于德特里克堡及其附近地区的白肺病情况。”
亚当斯的言论并不新鲜，自新冠疫情爆发以来，以美国为首的一些势力不讲科学、罔顾事实，把溯源当作政治工具，不择手段地对中国进行舆论攻击，“中国责任论”“中国赔偿论”轮番登场。
2021年3月30日，世卫组织专家组发布新冠病毒溯源联合研究报告，明确给出“实验室事故引发病毒是极不可能的”结论。但美国仍急不可耐地推动“病毒源自中国实验室”的叙事，对世卫组织联合专家组的科学结论和报告内容进行肆意曲解，往中国身上泼脏水。
然而在新冠病毒溯源问题上，美国自身存在诸多疑点，有待美国政府给全世界人民一个交代。2019年7月，美国陆军设在马里兰州的德特里克堡生物基地突然紧急关闭。几乎就在同时，一场所谓的 “电子烟肺炎”席卷美国多州。
据美国疾病控制与预防中心数据，与电子烟有关的急诊就诊人数在2019年大幅攀升，9月达到峰值后开始下降。截至2020年2月18日，全美报告了2807例电子烟导致的“肺损伤”住院或死亡病例。有美媒报道，这些患有与新冠肺炎相似症状疾病的人中，很可能有大量新冠肺炎患者。
2021年，千万中国民众联署呼吁世界卫生组织就新冠病毒溯源问题对美国德特里克堡实验室进行调查；此外，意大利媒体溯源新冠病毒的文章也指向美国德特里克堡，该媒体因此被美媒CNN攻击是在和中国“协同宣传”。
时至今日，美国仍然装聋作哑，没有开放德特里克堡及其海外生物实验室接受调查。